ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Funds 11 New Grants In Women’s Health Research.

September 29, 2000

Bone Marrow Transplant Survival Has Doubled In Young Patients

August 26, 2011

Joseph Simone Accepts Chief Physician Job At Memorial Hospital, Succeeding DeVita

February 21, 1992

Foundation offers funds for mesothelioma research.

July 9, 2004

In Brief: Ames, Rowley, Win National Science Medals; New Building Planned for Pittsburgh Center

January 8, 1999

Litton Sells Clinical Labs, Planning to Join Recompetition For FCRF Contracts

July 12, 1985